6713-41-3 Usage
General Description
Bicyclo[2.2.1]heptane-2,3-dicarboximide, also known as norbornene dicarboximide, is a chemical compound with the formula C9H9NO2. It belongs to the category of organic compounds known as dicarboximides, which are characterized by containing two carboximide groups. The structure of Bicyclo[2.2.1]heptane-2,3-dicarboximide is based on the norbornene structure, in which two carbon atoms are replaced by nitrogen atoms. It is sharp to the touch and has a mild acidity. This chemical is non-polar, has a high melting point, and is used in a variety of applications, including as a monomer in the production of polymers, in organic synthesis, and in the manufacture of rubber and plastics. It is also used in the manufacture of pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 6713-41-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,7,1 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6713-41:
(6*6)+(5*7)+(4*1)+(3*3)+(2*4)+(1*1)=93
93 % 10 = 3
So 6713-41-3 is a valid CAS Registry Number.
6713-41-3Relevant articles and documents
IBX-mediated oxidation of unactivated cyclic amines: application in highly diastereoselective oxidative Ugi-type and aza-Friedel-Crafts reactions
De Graaff,Bensch,Van Lint, Matthijs J.,Ruijter,Orru
supporting information, p. 10108 - 10112 (2015/10/20)
The first o-iodoxybenzoic acid (IBX) mediated oxidation of unactivated amines to imines is described. A range of meso-pyrrolidines were shown to be suitable substrates. The chemical space was further explored with one-pot oxidative Ugi-type and aza-Friedel-Crafts reactions, which proved to be highly diastereoselective.
DEUTERATED TANDOSPIRONE DERIVATIVES AS 5-HT1A RECEPTOR AGONISTS
-
Page/Page column 111, (2012/02/15)
The present invention relates to new deuterated derivatives of serotonin 5-HT1A receptor agonists of formula 1 and in particular to compositions and methods for therapeutic use.
